Impact of COVID-19 Vaccine Doses on Immunity and Disease Severity
Author Information
Author(s): Chen Daxiang, Zhang Weihong, Xiao Bin, Xu Banglao, Yang Xiaoyun, Deng Shidong, Li Guichang, Yang Gang, Cao Jinpeng, Mei Xinyue, Luo Qi, Huang Peiyu, Sun Xi, Su Jie, Zhong Nanshan, Zhao Zhuxiang, Wang Zhongfang
Primary Institution: Guangzhou Medical University
Hypothesis
How do different doses of the wild-type COVID-19 vaccine affect immunity against the BA.5 variant and the risk of reinfection with the XBB strain?
Conclusion
Receiving two to three doses of the wild-type COVID-19 vaccine significantly increases neutralizing antibody levels and reduces the severity of COVID-19 caused by the BA.5 variant.
Supporting Evidence
- Two to three doses of the wild-type vaccine significantly increased neutralizing antibody levels.
- Vaccination reduced the incidence of COVID-19-associated pneumonia.
- Individuals with two to three doses had a lower risk of reinfection with the XBB variant.
- RNA analysis showed increased B cell activation and reduced inflammation in vaccinated individuals.
- The study included a large sample size of 1,373 individuals.
Takeaway
Getting more doses of the COVID-19 vaccine helps your body fight off the virus better and makes you less sick if you catch it.
Methodology
The study assessed 1,373 individuals who received varying doses of the wild-type vaccine and measured their neutralizing antibody levels and disease severity after BA.5 infection.
Potential Biases
Potential biases may arise from the observational nature of the study and the specific population sampled.
Limitations
The study was conducted in a single hospital and may not represent broader populations.
Participant Demographics
Participants included individuals who received zero to three doses of the wild-type vaccine, with varying demographics.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website